In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments: In vitro augmentation of mesenchymal stem cells viability

Cell Stress and Chaperones

Volumn 20, Issue 2, 2015, Pages 237-251

  Amiri, Fatemeh ^a   Jahanian Najafabadi, Ali ^b   Roudkenar, Mehryar Habibi ^a  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bioreactor; Conditioned medium; Mesenchymal stem cell; Microenvironment; Preconditioning; Scaffold

Indexed keywords

BIOREACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; GENETIC MANIPULATION; HUMAN; HYPOXIA; IN VITRO STUDY; INFLAMMATION; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROENVIRONMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; ANIMAL; BIOLOGICAL THERAPY; CELL CULTURE TECHNIQUE; CELL HYPOXIA; CELL SURVIVAL; CYTOLOGY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; TISSUE ENGINEERING; TISSUE SCAFFOLD;

HEAT SHOCK PROTEIN 20; PROTEIN KINASE B;

ANIMALS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; HSP20 HEAT-SHOCK PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; PROTO-ONCOGENE PROTEINS C-AKT; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84925499785     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-014-0560-1     Document Type: Review

References (199)

1. Al-Nbaheen M et al (2013) Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev Rep 9:32–43
2. Amiri F, Halabian R, Dehgan Harati M, Bahadori M, Mehdipour A, Mohammadi Roushandeh A, Habibi Roudkenar M (2014a) Positive selection of Wharton’s jelly-derived CD105+ cells by MACS technique and their subsequent cultivation under suspension culture condition: a simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells Hematology
3. Amiri F, Halabian R, Salimian M, Shokrgozar MA, Soleimani M, Jahanian-Najafabadi A, Roudkenar MH (2014b) Induction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions Cell Stress and Chaperones:1–10
4. Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, Ovize M (2011) Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 30:95–102
5. Arno AI, Amini-Nik S, Blit PH, Al-Shehab M, Belo C, Herer E, Jeschke MG (2014) Effect of human Wharton’s jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts stem cells translational medicine:sctm. 2013–0120
6. Asakura S, Hurley RW, Skorstengaard K, Ohkubo I, Mosher DF (1992) Inhibition of cell adhesion by high molecular weight kininogen. J Cell Biol 116:465–476
7. Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy Frontiers in physiology 3
8. Bahmani B, Roudkenar MH, Halabian R, Jahanian-Najafabadi A, Amiri F, Jalili MA (2014) Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress Cell Stress and Chaperones:1–9
9. Baker BM, Chen CS (2012) Deconstructing the third dimension—how 3D culture microenvironments alter cellular cues. J Cell Sci 125:3015–3024
10. Banerjee M, Bhonde RR (2006) Application of hanging drop technique for stem cell differentiation and cytotoxicity studies. Cytotechnology 51:1–5
11. Bao C, Guo J, Lin G, Hu M, Hu Z (2008) TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI. Scand Cardiovasc J 42:56–62
12. Barboza CAG, Ginani F, Soares DM, Henriques ÁCG, Freitas RdA (2014) Low-level laser irradiation induces in vitro proliferation of mesenchymal stem cells Einstein (São Paulo) 12:75–81
13. Bartosh TJ et al (2010) Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci 107:13724–13729
14. Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, Strunk D, Klüter H (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331–2341
15. Biffi A et al (2013) Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341:1233158
16. Bizzarri A, Koehler H, Cajlakovic M, Pasic A, Schaupp L, Klimant I, Ribitsch V (2006) Continuous oxygen monitoring in subcutaneous adipose tissue using microdialysis. Anal Chim Acta 573:48–56
17. Boopathy AV, Pendergrass KD, Che PL, Yoon Y-S, Davis ME (2013) Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem Cell Res & therapy 4:1–15
18. Boyette LB, Tuan RS (2014) Adult stem cells and diseases of aging. J Clin Med 3:88–134
19. Brind’Amour K (2012) Ethics and induced pluripotent stem cells embryo project encyclopedia
20. Bruno S et al (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053–1067
21. Burova E, Borodkina A, Shatrova A, Nikolsky N (2013) Sublethal oxidative stress induces the premature senescence of human mesenchymal stem cells derived from endometrium oxidative medicine and cellular longevity 2013
22. Cai J et al. (2013a) Generation of tooth-like structures from integration-free human urine induced pluripotent stem cells Cell Regeneration 2
23. Cai T-Y, Zhu W, Chen X-S, Zhou S-Y, Jia L-S, Sun Y-Q (2013b) Fibroblast growth factor 2 induces mesenchymal stem cells to differentiate into tenocytes through the MAPK pathway. Molecular medicine reports 8:1323–1328
24. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838–848
25. Camussi G, Deregibus MC, Cantaluppi V (2013) Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans 41:283–287
26. Cantinieaux D et al (2013) Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One 8:e69515
27. Cardoso TC et al (2012) Isolation and characterization of Wharton’s jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system. BMC Biotechnol 12:18
28. Carpentier B, Layrolle P, Legallais C (2011) Bioreactors for bone tissue engineering. Int J Artif Organs 34:259–270
29. Chen H, J. A. W (2014) GW25-e1653 SIRT1 enhances therapeutic efficacy of aged mesenchymal stem cells in rat myocardial infarction via lightening MSCs aging and heightening stress resistance. J Am Coll Cardiol 64
30. Chen M et al (2012a) Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One 7:e28203
31. Chen X-D et al (2012b) Characterization of bone marrow derived mesenchymal stem cells in suspension. Stem Cell Res Ther 3:40
32. Cheng N-C, Wang S, Young TH (2012) The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. Biogeosciences 33:1748–1758
33. Choi MR, Kim SH, Ohn T, Jung KH, Chai YG (2014) Resveratrol relieves hydrogen peroxide-induced premature senescence associated with SIRT1 in human mesenchymal. Stem cells Mol & Cell Toxicol 10:29–39
34. Choo KB et al (2014) Oxidative stress-induced premature senescence in Wharton’s jelly-derived mesenchymal stem cells. J Med Sci 11:1201
35. Choudhery MS, Khan M, Mahmood R, Mehmood A, Khan SN, Riazuddin S (2012a) Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti‐apoptosis capabilities. Cell Biol Int 36:747–753
36. Choudhery MS et al (2012b) Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair‐infarcted myocardium. J Cell Mol Med 16:2518–2529
37. Choudhery MS, Badowski M, Muise A, Harris DT (2013) Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy 15:330–343
38. Collino F et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5:e11803
39. Cramer C et al (2010) Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 19:1875–1884
40. Cui H, Kong Y, Zhang H (2011) Oxidative stress, mitochondrial dysfunction, and aging Journal of signal transduction 2012
41. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R (2003) Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999–3001
42. Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. Int Society for Cellular Therapy position statement Cytotherapy 8:315–317
43. Donzelli E et al (2007) Mesenchymal stem cells cultured on a collagen scaffold: in vitro osteogenic differentiation. Arch Oral Biol 52:64–73
44. Drela K et al. (2014) Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner Cytotherapy
45. Ehninger A, Trumpp A (2011) The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208:421–428
46. Eitan Y, Sarig U, Dahan N, Machluf M (2009) A cellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility tissue engineering part C. Methods 16:671–683
47. El-Amin S, Lu H, Khan Y, Burems J, Mitchell J, Tuan R, Laurencin C (2003) Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials 24:1213–1221
48. Estrada J et al. (2013) Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy Cell death & disease 4:e691
49. Fehrer C et al (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging cell 6:745–757
50. Fischer B, Bavister B (1993) Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil 99:673–679
51. Fossett E, Khan W (2012) Optimising human mesenchymal stem cell numbers for clinical application: a literature review Stem cells international 2012
52. Francois S, Mouiseddine M, Allenet-Lepage B, Voswinkel J, Douay L, Benderitter M, Chapel A (2013) Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects BioMed research international 2013
53. Frith JE, Thomson B, Genever PG (2009) Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential tissue engineering part C. Methods 16:735–749
54. Fu W-L et al (2011) Proliferation and apoptosis property of mesenchymal stem cells derived from peripheral blood under the culture conditions of hypoxia and serum deprivation. Chinese Medical Journal-Beijing 124:3959
55. Gao F, He T, Wang H, Yu S, Yi D, Liu W, Cai Z (2007) A promising strategy for the treatment of ischemic heart disease: mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol 23:891–898
56. Garbern JC, Lee RT (2013) Cardiac stem cell therapy and the promise of heart regeneration cell. Stem Cell 12:689–698
57. Gharibi B, Farzadi S, Ghuman M, Hughes FJ (2014) Inhibition of Akt/mTOR attenuates age‐related changes in mesenchymal stem cells STEM CELLS
58. Godara P, McFarland CD, Nordon RE (2008) Design of bioreactors for mesenchymal stem cell tissue engineering. J Chem Technol Biotechnol 83:408–420
59. Greco SJ, Rameshwar P (2012) Mesenchymal stem cells in drug/gene delivery: implications for cell therapy. Ther Deliv 3:997–1004
60. Haider HK, Ashraf M (2008) Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45:554–566
61. Haider KH, Jiang S, Idris NM, Ashraf M (2008) IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300–8
62. Haines DD, Juhasz B, Tosaki A (2013) Management of multicellular senescence and oxidative stress. J Cell Mol Med 17:936–957
63. Halabian R, Tehrani HA, Jahanian-Najafabadi A, Roudkenar MH (2013) Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments. Cell Stress and Chaperones 18:785–800
64. Halme DG, Kessler DA (2006) FDA regulation of stem-cell-based therapies. N Engl J Med 355:1730–1735
65. Hamedi-Asl P et al (2012) Adenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses. Cell Stress and Chaperones 17:181–190
66. Hammoud M et al (2012) Combination of low O2 concentration and mesenchymal stromal cells during culture of cord blood CD34+ cells improves the maintenance and proliferative capacity of hematopoietic stem cells. J Cell Physiol 227:2750–2758
67. Han J, Mistriotis P, Lei P, Wang D, Liu S, Andreadis ST (2012) Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 30:2746–2759
68. Han Q, Fan L, Heng BC, Zigang GE (2013) Apoptosis and metabolism of mesenchymal stem cells during chondrogenic differentiation in vitro. Int J Tissue Regen 4:61–64
69. Han S-M et al. (2014) Enhanced proliferation and differentiation of Oct4-and Sox2-overexpressing human adipose tissue mesenchymal stem cells Experimental & molecular medicine 46:e101
70. Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12
71. He A, Jiang Y, Gui C, Sun Y, Li J, Wang JA (2009) The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. Can J Cardiol 25:353–358
72. Herberts CA, Kwa M, Hermsen H (2011) Risk factors in the development of stem cell therapy. J Transl Med 9:29
73. Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR (2010) Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock 33:24–30
74. Higuchi O, Okabe M, Yoshida T, Fathy M, Saito S, Miyawaki T, Nikaido T (2012) Stemness of human Wharton’s jelly mesenchymal cells is maintained by floating cultivation cellular reprogramming. Formerly “Cloning and Stem Cells” 14:448–455
75. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ (2010) Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 21:1513–1526
76. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549–580
77. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135:799–808
78. Huebsch N et al (2010) Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 9:518–526
79. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ (2007) Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K‐Akt pathway in hypoxic endothelial cells to inhibit apoptosis. Increase Survival, and Stimulate Angiogenesis Stem Cells 25:2363–2370
80. Ishihara K, Ishikawa E, Iwasaki Y, Nakabayashi N (1999) Inhibition of fibroblast cell adhesion on substrate by coating with 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomater Science Polymer Edition 10:1047–1061
81. Ito D, Yagi T, Suzuki N (2013) [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases] Brain and nerve = Shinkei kenkyu no shinpo 65:283–288
82. Iwase T et al (2005) Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 66:543–551
83. J Salgado A, L Reis R, Sousa N, M Gimble J (2010) Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine Current stem cell research & therapy 5:103–110
84. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071–1078
85. Jäderstad J, Brismar H, Herlenius E (2010) Hypoxic preconditioning increases gap-junctional graft and host communication. Neuroreport 21:1126–1132
86. Jin HJ et al (2013) Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 14:17986–18001
87. Jones DL, Wagers AJ (2008) No place like home: anatomy and function of the stem cell niche. Nature Reviews Molecular Cell Biology 9:11–21
88. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T, Saijo Y (2010) Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 19:196–203
89. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89–116
90. Khan M et al (2013) Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart. Stem Cell Res Ther 4:58
91. Kiani AA, Abdi J, Halabian R, Roudkenar MH, Amirizadeh N, Soleiman Soltanpour M, Kazemi A (2014) Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model. Hematology 19:85–98
92. Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27:1050–1056
93. Koliakos I, Tsagias N, Karagiannis V (2011) Mesenchymal cells isolation from Wharton’s jelly, in perspective to clinical applications. J Biol Res 16:194–201
94. Krinner A, Hoffmann M, Loeffler M, Drasdo D, Galle J (2010) Individual fates of mesenchymal stem cells in vitro. BMC Syst Biol 4:73
95. Kuhn LT et al (2013) Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng A 20:365–377
96. Lavrentieva A, Majore I, Kasper C, Hass R (2010) Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal 8:18
97. Law S, Chaudhuri S (2013) Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. American journal of stem cells 2:22
98. Lee J-M, Johnson JA (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. BMB Rep 37:139–143
99. Lee JS, Lee MO, Moon BH, Shim SH, Fornace AJ, Cha HJ (2009a) Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1‐mediated downregulation of intrinsic stress signaling pathways. Stem Cells 27:1963–1975
100. Lee KA et al (2009b) Analysis of changes in the viability and gene expression profiles of human mesenchymal stromal cells over time. Cytotherapy 11:688–697
101. Lee MW, Jang IK, Yoo KH, Sung KW, Koo HH (2010) Stem and progenitor cells in human umbilical cord blood. Int J Hematol 92:45–51
102. Lee SK et al (2012) Phosphatase of regenerating liver‐3 promotes migration and invasion by upregulating matrix metalloproteinases‐7 in human colorectal cancer cells. Int J Cancer 131:E190–E203
103. Li Y, Lin F (2012) Mesenchymal stem cells are injured by complement after their contact with serum. Blood 120:3436–3443
104. Li W et al (2007) Bcl‐2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25:2118–2127
105. Li S, Deng Y, Feng J, Ye W (2009) Oxidative preconditioning promotes bone marrow mesenchymal stem cells migration and prevents apoptosis. Cell Biol Int 33:411–418
106. Li Q, Wang Y, Deng Z (2013a) Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy. Stem cell research & therapy 4:1–3
107. Li X, Zhang Y, Qi G (2013b) Evaluation of isolation methods and culture conditions for rat bone marrow mesenchymal. Stem cells Cytotechnology 65:323–334
108. Li D, Xu Y, Gao C, Zhai Y (2014) Adaptive protection against damage of preconditioning human umbilical cord-derived mesenchymal stem cells with hydrogen peroxide Genetics and molecular research: GMR 13
109. Lindenmair A et al (2012) Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells 1:1061–1088
110. Linero I, Chaparro O (2014) Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS One 9:e107001
111. Liu TM, Wu YN, Guo XM, Hui JHP, Lee EH, Lim B (2009) Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev 18:1013–1022
112. Liu H et al (2010) Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. Biochem Biophys Res Commun 401:509–515
113. Liu N et al (2011) Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. J Transl Med 9:105
114. Liu TM et al (2012) Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev 22:268–278
115. Liu Y, Yang R, He Z, Gao W-Q (2013) Generation of functional organs from stem cells. Cell Regeneration 2:1
116. Lodi D, Iannitti T, Palmieri B (2011) Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res 30:1–20
117. Lu H, Li Y, Sheng Z, Wang Y (2012) Preconditioning of stem cells for the treatment of myocardial infarction. Chin Med J (Engl) 125:378–384
118. Lund AW, Yener B, Stegemann JP, Plopper GE (2009) The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng B Rev 15:371–380
119. Luo Y et al. (2012) SURGICAL RESEARCH REVIEW Surgery
120. Ma T, Grayson WL, Fröhlich M, Vunjak‐Novakovic G (2009) Hypoxia and stem cell‐based engineering of mesenchymal tissues. Biotechnol Prog 25:32–42
121. Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y (2013) Immunobiology of mesenchymal stem cells Cell Death & Differentiation
122. Mahmood A, Wu H, Qu C, Mahmood S, Xiong Y, Kaplan D, Chopp M (2014) Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats. Brain Res 1542:41–48
123. Malard F, Mohty M (2014) New insight for the diagnosis of gastrointestinal acute graft-versus-host disease mediators of inflammation 2014
124. Mansouri L, Xie Y, Rappolee DA (2012) Adaptive and pathogenic responses to stress by stem cells during development. Cells 1:1197–1224
125. McGinley L, McMahon J, Strappe P, Barry F, Murphy M, O’Toole D, O’Brien T (2011) Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia Stem Cell Res Ther 2:12
126. Meier RP et al (2013) Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res 11(3):1348–64
127. Meinel L et al (2004) Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32:112–122
128. Mennan C, Wright K, Bhattacharjee A, Balain B, Richardson J, Roberts S (2013) Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord BioMed research international 2013
129. Mertes H, Pennings G (2009) Cross-border research on human embryonic stem cells: legal and ethical considerations. Stem Cell Rev Rep 5:10–17
130. Mirotsou M et al (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci 104:1643–1648
131. Mohammadzadeh M et al (2012) Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity. Cell Stress and Chaperones 17:553–565
132. Moll G et al (2012) Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells 30(7):1565–74
133. Murphy MB, Moncivais K, Caplan AI (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine Experimental & molecular medicine 45:e54
134. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
135. Muturi HT, Dreesen JD, Nilewski E, Jastrow H, Giebel B, Ergun S, Singer BB (2013) Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior. PLoS One 8:e74654
136. Naderi‐Meshkin H, Bahrami AR, Bidkhori HR, Mirahmadi M, Ahmadiankia N (2014) Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy Cell biology international
137. Noiseux N et al (2004) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14:840–850
138. Nystedt J et al (2013) Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells. Stem Cells 31(2):317–26
139. Oh JS et al (2010) Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model. Neurosci Lett 472:215–219
140. Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H, Ueda M (2012) Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng A 18:1479–1489
141. Paschos KA, Bird NC (2010) Liver regeneration and its impact on post-hepatectomy metastatic tumour recurrence. Anticancer Res 30:2161–2170
142. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134–142
143. Pendergrass KD, Boopathy AV, Seshadri G, Maiellaro-Rafferty K, Che PL, Brown ME, Davis ME (2013) Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury. Stem Cells Dev 22:2414–2424
144. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103:1647–1652
145. Ponader S, Burger JA (2010) Modeling the marrow stem cell niche in vitro: is proximity the key to reproduction? Haematologica 95:e5
146. Potier E, Ferreira E, Andriamanalijaona R, Pujol J-P, Oudina K, Logeart-Avramoglou D, Petite H (2007a) Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40:1078–1087
147. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, Petite H (2007b) Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13:1325–1331
148. Przybyla LM, Theunissen TW, Jaenisch R, Voldman J (2013) Matrix remodeling maintains embryonic stem cell self‐renewal by activating atat3 stem cells 31:1097–1106
149. Ramsey F (2011) A simple hanging drop cell culture protocol for generation of 3D spheroids Journal of Visualized Experiments
150. Ratajczak MZ (2011) The emerging role of microvesicles in cellular therapies for organ/tissue regeneration. Nephrol Dial Transplant 26:1453–1456
151. Ren H et al (2006) Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun 347:12–21
152. Ren G et al (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141–150
153. Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y, Shi Y (2012) Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem cells translational medicine 1:51–58
154. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707–1710
155. Ribeiro A et al (2013) Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem cell research & therapy 4:125
156. Robey TE, Saiget MK, Reinecke H, Murry CE (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45:567–581
157. Saunders A, Faiola F, Wang J (2013) Concise review: pursuing self‐renewal and pluripotency with the stem cell factor Nanog. Stem Cells 31:1227–1236
158. Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441:1075–1079
159. Scaglione S, Giannoni P, Quarto R (2011) Cell-biomaterial interactions reproducing a Niche ADVANCES IN REGENERATIVE MEDICINE:363
160. Seaberg RM, Van Der Kooy D (2003) Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci 26(3):125–131
161. Shi W et al (2012) BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials 33:3119–3126
162. Shtrichman R, Germanguz I, Eldor JI (2013) Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine. Current molecular medicine 13:792–805
163. Sikavitsas VI, Bancroft GN, Mikos AG (2002) Formation of three‐dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 62:136–148
164. Singh P, Schwarzbauer JE (2012) Fibronectin and stem cell differentiation—lessons from chondrogenesis. J Cell Sci 125:3703–3712
165. Song M et al (2013) The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder. Stem Cells Dev 23:654–663
166. Stolzing A, Coleman N, Scutt A (2006) Glucose-induced replicative senescence in mesenchymal. Stem cells Rejuvenation research 9:31–35
167. Stolzing A, Sellers D, Llewelyn O, Scutt A (2010) Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs 191:453–465
168. Stolzing A, Bauer E, Scutt A (2012) Suspension cultures of bone-marrow-derived mesenchymal stem cells: effects of donor age and glucose level. Stem Cells Dev 21:2718–2723
169. Sundin M, Ringdén O, Sundberg B, Nava S, Götherström C, Le Blanc K (2007) No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92:1208–1215
170. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
171. Tan J et al (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307:1169–1177
172. Tang J et al (2009a) Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 36:644–650
173. Tang YL et al (2009b) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104:1209–1216
174. Tarte K et al (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:1549–1553
175. Tetta C, Bruno S, Fonsato V, Deregibus MC, Camussi G (2011) The role of microvesicles in tissue repair. Organogenesis 7:105–115
176. Toh WS, Lee EH, Cao T (2011) Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. Stem Cell Rev Rep 7:544–559
177. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult. Murine heart Circulation 105:93–98
178. Tower J (2012) Stress and stem cells. WIREs Dev Biol 1:789–802
179. van den Akker F, de Jager S, Sluijter J (2013) Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors Mediators of inflammation 2013
180. Van Der Sanden B, Dhobb M, Berger F, Wion D (2010) Optimizing stem cell culture. J Cell Biochem 111:801–807
181. Wang JA et al (2008) Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 29:74–82
182. Wang X et al (2009) Hsp20‐engineered mesenchymal stem cells Are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells 27:3021–3031
183. Wang H et al (2013) Human mesenchymal stem cell transplantation changes proinflammatory gene expression through a nuclear factor‐κB‐dependent pathway in a rat focal cerebral ischemic model. J Neurosci Res 91(11):1440–9
184. Wang F et al. (2014a) Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro European journal of pharmacology
185. Wang X, Mei J, Liao C, Zhang L, Li M, Ding Q, Li S (2014b) Relationship between mesenchymal stem cells and liver cancer recurrence after liver transplantation in mice. Zhonghua yi xue za zhi 94:455–458
186. Wei H, Li Z, Hu S, Chen X, Cong X (2010) Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem 111:967–978
187. Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF (2013) Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34:747–754
188. Whu SW, Tsai C-L, S-h H (2009) Evaluation of human bone marrow mesenchymal stem cells seeded into composite scaffolds and cultured in a dynamic culture system for neocartilage regeneration in vitro. J Med Biol Eng 29:52–59
189. Willerth SM, Sakiyama-Elbert SE (2008) Combining stem cells and biomaterial scaffolds for constructing tissues and cell delivery
190. Wong RS (2011) Mesenchymal stem cells: angels or demons? BioMed Research International 2011
191. Wu Y-h, Wang J, Gong D-x G, H-y H, S-s ZH (2012) Effects of low-level laser irradiation on mesenchymal stem cell proliferation: a microarray analysis. Lasers Med Sci 27:509–519
192. Xu J et al (2012) High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci 13:17104–17120
193. Yang CC, Wang J, Chen SC, Hsieh YL (2013) Synergistic effects of low‐level laser and mesenchymal stem cells on functional recovery in rats with crushed sciatic nerves Journal of tissue engineering and regenerative medicine
194. Yeatts AB, Fisher JP (2011) Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone 48:171–181
195. Yoon D, Kim Y, Jung H, Paik S, Lee J (2011) Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low‐density culture. Cell Prolif 44:428–440
196. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33:907–921
197. Zhang J et al (2012) Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton’s jelly mesenchymal stem cells after myocardial infarction. Chin Med J (Engl) 125:3472–3478
198. Zhu W, Chen J, Cong X, Hu S, Chen X (2006) Hypoxia and serum deprivation‐induced apoptosis in mesenchymal stem cells. Stem Cells 24:416–425
199. Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD (2013) Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie 95:2235–45